bleomycin medication used treat includes hodgkins lymphoma nonhodgkins lymphoma testicular cancer ovarian cancer cervical cancer among typically used cancer given intravenously injection muscle may also administered inside chest help prevent recurrence pleural effusion due cancer however talc better common side effects include fever weight loss vomiting severe type anaphylaxis may may also cause inflammation lungs result lung chest xrays every couple weeks recommended check bleomycin may cause harm baby used believed primarily work preventing synthesis bleomycin discovered world health organizations list essential available generic made bacterium streptomyces bleomycin mostly used treat includes testicular cancer ovarian cancer hodgkins disease less commonly nonhodgkins given intravenously intramuscular injection may also put inside chest help prevent recurrence pleural effusion due however scarring pleura talc appears better option although indwelling pleural catheters least effective reducing symptoms effusionsuch potentially effective bacterial infections toxicity prevents use studied treatment warts unclear common side effects flulike symptoms include fever rash dermatographism hyperpigmentation alopecia hair loss chills raynauds phenomenon discoloration fingers toes serious complication bleomycin occurring upon increasing dosage pulmonary fibrosis impaired lung function suggested bleomycin induces sensitivity oxygen recent studies support role proinflammatory cytokines mechanism bleomycininduced lung previous treatment bleomycin therefore always disclosed anaesthetist prior undergoing procedure requiring general anaesthesia due oxygen sensitive nature bleomycin theorised increased likelihood developing pulmonary fibrosis following supplemental oxygen therapy questioned whether patients take part scuba diving following treatment bleomycin also found disrupt sense bleomycin exceed lifetime cumulative dose greater pulmonary toxicities commonly presenting pulmonary fibrosis associated doses bleomycin greater bleomycin acts induction dna strand studies suggest bleomycin also inhibits incorporation thymidine dna strands dna cleavage bleomycin depends oxygen metal ions least vitro exact mechanism dna strand scission unresolved suggested bleomycin chelates metal ions primarily iron producing pseudoenzyme reacts oxygen produce superoxide hydroxide free radicals cleave dna alternative hypothesis states bleomycin may bind specific sites dna strand induce scission abstracting hydrogen atom base resulting strand cleavage base undergoes criegeetype rearrangement forms alkalilabile addition complexes also mediate lipid peroxidation oxidation cellular molecules therefore bleomycin used combination doxorubicin hodgkins lymphoma additive complementary effects dna since doxorubicin acts intercalating dna strands also acts topoisomerase ii enzyme thus relaxing topoisomerase complexescitation needed bleomycin nonribosomal peptide hybrid peptidepolyketide natural product peptidepolyketidepeptide backbone bleomycin aglycon assembled bleomycin megasynthetase made nonribosomal peptide synthetase nrps polyketide synthase pks modules nonribosomal peptides polyketides synthesized amino acids short carboxylic acids nrpss pkss respectively nrpss pkss use similar strategies assembly two distinct classes natural products nrps type pkss organized modules structural variations resulting peptide polyketide products determined number order modules nrps pks proteincitation needed biosynthesis bleomycin aglycon visualized three stagescitation needed basis bleomycin structure deduced functions individual nrps pks domains modules linear model bleomycin megasynthetasetemplated assembly bleomycin peptidepolyketidepeptide aglycon proposed nine amino acids one acetatecitation needed biosynthesis bleomycin completed glycosylation aglycones bleomycin naturally occurringanalogues two three sugar molecules dna cleavage activities analogues primarily plasmid relaxation break light assays bleomycin first discovered japanese scientist hamao umezawa found anticancer activity screening culture filtrates streptomyces verticillus umezawa published discovery drug launched japan nippon kayaku us bleomycin gained fda approval july initially marketed us bristolmyers squibb precursor bristol laboratories brand name blenoxane bleomycin used research induce pulmonary fibrosis httpsenwikipediaorgwikibleomycin